Opinion: STAT+: What Mark Cuban gets wrong about prescription drugs
STAT
AUGUST 10, 2023
Cuban claims the reason behind the success of Cost Plus Drugs is the company’s decision to bypass pharmaceutical benefit managers — the negotiating agents insurance companies hire to negotiate big pharma’s prices down. Meanwhile, generic drug companies saved the U.S. roughly $2.6
Let's personalize your content